Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Steven M. Sellers
The Alabama Supreme Court ruled 8-1 that a plaintiff could sue Wyeth, Inc., Reglan’s manufacturer, for injuries caused by a generic version produced by another manufacturer. The decision distinguished Pliva, Inc. v. Mensing, holding that Wyeth could be liable for its misrepresentations about the drug’s risks even when a patient is treated only with the generic version of the medication. Louis Bograd, senior litigation counsel for the Center for Constitutional Litigation in Washington, D.C., called the ruling “a lifeline to plaintiffs injured by inadequately labeled generic drugs.”